Overview

Efficacy and Safety of Three Different Latanoprost 0,005% Eyedrops in Subjects Affected by Primary Open Angle Glaucoma

Status:
Unknown status

Trial end date:
2012-07-01

Target enrollment:

Participant gender:

Summary

This study examines efficacy and tolerability of 3 different Latanoprost 0.005% eyedrops preparations, commercially available in Italy, in subjects affected by primary open angle glaucoma.

Phase:

Phase 4

Details

Lead Sponsor:

University of Cantanzaro
University of Catanzaro

Treatments:

Latanoprost
Ophthalmic Solutions
Tetrahydrozoline